AQR Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $607K | Sell |
|
|||||
|
2023
Q1 | $554K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $284K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $393K | Sell |
|
|||||
|
2020
Q3 | $378K | Sell |
|
|||||
|
2020
Q2 | $2.4M | Sell |
|
|||||
|
2020
Q1 | $2.27M | Buy |
|
|||||
|
2019
Q4 | $2.06M | Sell |
|
|||||
|
2019
Q3 | $884K | Sell |
|
|||||
|
2019
Q2 | $1.07M | Sell |
|
|||||
|
2019
Q1 | $1.59M | Sell |
|
|||||
|
2018
Q4 | $1.06M | Buy |
|
|||||
|
2018
Q3 | $381K | Sell |
|
|||||
|
2018
Q2 | $263K | Sell |
|
|||||
|
2018
Q1 | $227K | Hold |
|
|||||
|
2017
Q4 | $313K | Sell |
|
|||||
|
2017
Q3 | $418K | Buy |
|